U.S. farms swapping corn for soybeans as profit margin widens
While corn is still king, farmers from North Dakota to Texas are preparing to use more of their land on soybeans instead. And the reason why is obvious.
Bloomberg News
Articles
Anthem, Cigna blast one another over blocked insurer merger
Cigna Corp. and Anthem Inc. are trading accusations of harassment and sabotage in competing lawsuits as the two health companies feud publicly in the wake of a stalled $48 billion merger.
Judge blocks Cigna from scuttling $48 billion deal with Anthem
Indianapolis-based Anthem Inc. on Wednesday won a court ruling blocking Cigna Corp. from terminating a proposed merger between the health insurers until a judge could weigh arguments over the faltering deal at an April 10 hearing.
Merck stops Alzheimer’s study after ‘no chance’ of benefit
Merck & Co. on Tuesday announced that it will end a study of its once-promising Alzheimer’s disease drug in patients with mild-to-moderate forms of the condition, just three months after Eli Lilly and Co. announced its own setback in a field that’s been littered with failures.
Cigna seeks to terminate merger with Anthem, sues insurer for $13B
Indianapolis-based Anthem responded almost immediately Tuesday by saying Cigna does not have the right to cancel the deal.
Yellen sees more rate hikes ahead if economy stays on course
Federal Reserve Chairwoman Janet Yellen said more interest-rate increases will be appropriate if the U.S. economy meets the central bank’s outlook of gradually rising inflation and tightening labor markets.
Aetna gives up on $34B Humana deal, will pay $1B breakup fee
The Humana-Aetna deal was one of two mergers that would have reshaped the U.S. health insurance landscape. Both were rejected by federal judges as anticompetitive. Anthem hasn't given up on its deal—a $48 billion pact to acquire Cigna—and is pressing ahead with an appeal.
After megadeals blocked, health insurers plotting next moves
Anthem filed a notice of appeal on Thursday after a federal judge blocked its $48 billion deal to buy Cigna Corp.
Dying patients have Pence’s backing on ‘right to try’ policy
Vice President Mike Pence may have just picked another fight with pharmaceutical companies—one that doesn’t involve drug prices.
Anthem’s $48B bid for Cigna blocked by judge as anticompetitive
The deal, along with Aetna Inc.’s proposed tie-up with Humana Inc., which was blocked last month, was set to reduce the ranks of big U.S. health insurers to three from five and make Anthem the largest by membership.
More employers starting to deal with death, dying in benefits packages
Companies have spent the last few years beefing up their parental-leave policies to attract and retain the most sought-after workers. Up next in the benefits arms race: helping workers deal with sickness and death.
Hudson’s Bay reportedly in early takeover talks with Macy’s
If a deal occurs, Hudson’s Bay might fold Macy’s assets, worth about $20 billion, into HBS Global Properties, its joint venture with Indianapolis-based Simon Property Group.
Lilly CEO encouraged by Trump meeting, concerned about Obamacare
Eli Lilly and Co. CEO Dave Ricks said he was encouraged by President Donald Trump’s understanding of the complexities of drug development, yet he’s concerned about risks the industry may face in a fresh overhaul of the U.S. health-care system.
Trump spoils pharma chiefs with no more bad news on drug pricing
For drugmakers, including Indianapolis-based Eli Lilly and Co., a meeting Tuesday with President Donald Trump was a dose of happy pills.
UPDATE: Trump tells drugmakers, including Lilly, their prices are ‘astronomical’
President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
Trump to require two rules be killed for each new one
President Trump is fulfilling a promise he made shortly after his election to reduce federal regulations. In practice, the policy potentially requires months of study and public input for each regulation eliminated.
Dealmakers wonder if Trump will intervene in mergers
It wasn’t a surprise when Donald Trump took the opportunity during his Jan. 11 press conference to angrily accuse CNN of spreading fake news. Throughout the campaign Trump had complained the cable network was being unfair to him—and at one point vowed that as president, he would block AT&T Inc.’s proposed $85.4 billion merger with […]
Longtime Formula One leader Ecclestone to be replaced
The leadership change was announced Monday as Liberty Media Corp. completed the $4.4 billion acquisition of Formula One from private equity firm CVC Capital Partners.
BlueIndy owner’s battery company leaving investors on side of road
French billionaire Vincent Bollore’s push into electric vehicles has been a huge success, at least in terms of publicity and eye-catching contracts. For investors, it hasn’t worked out so well.
Cause of ailing flight attendants creates mystery, controversy
From oozing blisters and wheezing to rashes, itchy eyes, and sore throats, numerous flight attendants at one of the country’s largest airlines say their new work uniforms are making them sick.